1Bu W, Tang ZY, Sun FX, et al. Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic modele LCI-D20. Hepatogastrostroenterology, 1998, 45: 1056-1061. 被引量：1
2Yoshiji H, Kuriyama S, Hicklin DJ, et al. KDR/flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma. Hepatology, 1998,30:1179-1186. 被引量：1
2Kuyvenhoven JP,Van-Hock B,Blom E,et al.Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.Thromb Haemost,2003,89(4):718-725. 被引量：1
3Kleiner DE,Stetler-Stevenson WG.Matrix metalloproteinases and metastasis.Cancer Chemother Pharmacol.1999,43(Suppl):S42-S51. 被引量：1
4Mckenna GJ,Chen Y,Smith RM,et al.A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas.Am J Surg,2002,183(5);588-594. 被引量：1
5Schoedel KE,Tyner VZ,Kim TH,et al.HGF,MET,and matrix-related proteases in hepatocellular carcinoma,fibrolamellar variant,cirrhotic and normal liver.Mod Pathol,2003,16(1):14-21. 被引量：1
6Gohji K,Fujimoto N,Hara I,et al.Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extention.Int J Cancer,1998,79(1):96-101. 被引量：1
7Sakamoto Y,Mafune K,Mori M,et al.Overexpression of MMP-9 correlates with growth of a small hepatocellular carcinoma.Int J Oncol,2000,17(2):237-243. 被引量：1
8Yoshizaki T,Sato H,Furukawa M.Recent advances in the regulation of matrix metalloproteinase 2 activation:from basic research to clinical implication.Oncol Rep,2002,9(3):607-611. 被引量：1
9Schoenermark MP,Mitchell TI,Rutter JL,et al.Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis.Ann N Y Acad Sci,1999,878:466-486. 被引量：1
2Passlick B, Sienel W, Seen-Hibler R, et al. Over expression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer[J]. Clin Cancer Res, 2000, 6(10):3944-3948. 被引量：1
3Zheng H, Takahashi H, Murai Y, et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma [J]. Anticancer Res, 2006, 26(5A):3579-3583. 被引量：1
4Quaranta M, Daniele A, Coviello M, et al. MMP-2, MMP- 9, VEGF and CA 15.3 in breast cancer [J]. Anticancer Res, 2007, 27(5B):3593-3600. 被引量：1
5Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma[J]. Cancer, 1996, 77(5):858-863. 被引量：1
6Maehara Y, Kabashima A, Koga T, et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma[J]. Surgery, 2000, 128(3):408-416. 被引量：1
7Monig SP, Baldus SE, Hennecken JK, et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma[J]. Histopathology, 2001, 39(6):597-602. 被引量：1
8Sundblad A, Rieci k MMP-2 expression(type IV collagenase) in gastric cancer[J]. Aeta Gastroenterol Latinoam, 1998, 28(4):287-290. 被引量：1
9Tolnay E, Wiethege T, Kuhnen C, et al. Expression of type IV collagenase correlations with the expression of vascular endothelial growth factor in primary non-small cell lung cancer[J]. J Cancer Res Clin Oncol, 1997,123(5):652-658. 被引量：1
10Garzetti G, Andrea C, Guendalina L, et al. Expression of vascular endothelial growth factor related to 72-kilodahon metalloproteinase immunostaining in patients with serous ovarian tumor[J]. Cancer, 1999, 85(10):2219-2225. 被引量：1
